Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children

Journal of Neuro-Oncology

Volumn 42, Issue 2, 1999, Pages 143-150

  Czech, Thomas ^a   Slave, Irene ^b   Aichholzer, Martin ^a   Haberler, Christine ^c   Dietrich, Wolfgang ^a   Dieckmann, Karin ^b   Koos, Wolfgang ^a   Budka, Herbert ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anaplastic transformation; Leptomeningeal spread; MIB 1 labeling index; Radiotherapy; Visual pathway glioma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; DEATH; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LABELING INDEX; LEPTOMENINX; MALE; METASTASIS; NEUROFIBROMATOSIS; TIME; TUMOR GROWTH;

ADOLESCENT; ANTIGENS, NUCLEAR; ASTROCYTOMA; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; CELL CYCLE; CELL DIVISION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KI-67 ANTIGEN; MALE; MITOTIC INDEX; NUCLEAR PROTEINS; PROGNOSIS; REOPERATION; TIME FACTORS; VISUAL PATHWAYS;

EID: 0033035198     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006244724476     Document Type: Article

References (37)

1. Dutton JJ: Gliomas of the anterior visual pathway. Survey of Ophthalmology 38: 427-451, 1994
2. Meleu O: Ophthalmic manifestations of brain tumors. In: Peyman GA, Sanders DR, Goldberg MF (eds) Principles and Practices of Ophthalmology. WB Saunders Company, Philadelphia, 1980, pp 2012-2015
3. Hoffman HJ, Humphrey RO, Drake JM, Rutka JT, Becker LE, Jenkins D, Greenberg M: Optic pathway/hypothalamic gliomas: A dilemma in management.Pediatr Neurosurg 19: 186-195, 1993
4. Garvey M, Packer RJ: An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol 28: 167-183, 1996
5. Sutton LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB, Moshang T Jr, Lange P, Packer RJ: Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 83: 583-589, 1995
6. Duffner PK, Cohen ME, Thomas PR, Lansky SB: The long-term effects of cranial irradiation on the central nervous system. Cancer 56: 1841-1846, 1985
7. Ellenberg L, McComb JG, Siegel SE, Stowe S: Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21: 638-644, 1987
8. Jenkins D, Angyalfi S, Becker L, Berry M, Buncic R, Chan H, Doherty M, Drake J, Greenberg M, Hendrick B: Optic glioma in children: surveillance, resection or irradiation. Int J Radiat Oncol Biol Phys 25: 215-225, 1993
9. Pierce SM, Barnes PD, Loeffler JS, McGinn C, Tarbell NJ: Definitive radiation therapy in the management of symptomatic patients with optic glioma. Cancer 65: 45-52, 1990
10. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jackcki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM: Carboplatin and vincristin for children with newly diagnosed progressive low grade gliomas. J Neurosurg 86: 747-754, 1997
11. Petronio J, Edwards MSB, Prados M, Freyberger S, Rabbitt J, Silver P, Levin VA; Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74: 701-708, 1991
12. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, Helin HJ: Prognostication of astrocytoma patient survival by KI-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin embedded samples. J Pathol 174: 275-282, 1994
13. Germano IM, Ito M, Cho KG, Hoshino T, Davis RL, Wilson CB: Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 69: 839-842, 1988
14. Hoshino T, Rodriguez LA, Cho KG, Lee KS, Wilson CB, Edwards MS, Levin VA, Davis RL: Prognostic implications of the proliferative potential of low-grade astrocytomas. J Neurosurg 69: 839-842, 1988
15. Hsu DW, Louis DN, Efird JT, Hedley-Whyte TE: Use of MIB-1 (Ki67) Immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Experiment Neurol 56: 857-865, 1997.
16. Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A Stamoulis G, Seretis A, Thomas TE: MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Br J Cancer 75: 1269-1278, 1997
17. Labrousse F, Daumas-Duport C, Batorski L, Hoshino T: Histological grading and bromodeoxyuridine labeling index of astrocytomas. J Neurosurg 75: 202-205, 1991
18. Prados MD, Krouwer HGJ, Edwards MSB, Cogen PH, Davis RL, Hoshino T: Proliferative potential and outcome in pediatric astrocytic tumors. J Neurooncol 13: 277-282, 1992
19. Schiffer D, Cavalla P, Chio A, Richiardi P, Giordano MT: Proliferative activity and prognosis of low-grade astrocytoma. J Neurooncol 34: 31-35, 1997
20. MeKeever PE, Ross DA, Strawderman MS, Brunberg JA, Greenberg HS, Junck L: A comparison of the predictive power for survival in gliomas provided by MIB-1, Bromodeoxyuridine and Proliferative Cell Nuclear Antigen with histopathologic and clinical parameters. J Neuropath Experiment Neurol 56: 798-805, 1997
21. Pollack JF, Campbell JW, Hamilton RJ, Martinez AJ, Bozik ME: Proliferative index as a predictor of prognosis in malignant gliomas of childhood. Cancer 79: 849-856, 1997
22. Ito S, Hoshino T, Shibuya M, Prados MD, Edwards MS, Davis RL: Proliferative characteristics of juvenile pilocytic astrocytomas determined by Bromodeoxyuridine labeling. Neurosurgery 31: 413-419, 1992
23. Kleihues P, Burger OC, Scheithauer BW: Histologic typing of tumours of the central nervous system. Springer-Verlag, Berlin, 1993
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
25. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: analysis and examples. Br J Cancer 35: 1-39, 1977
26. Pearson WH: Estimation of correlation coefficient from an uncertainty measure. Psychometrika 31: 421-433, 1966
27. Cox DR: Regression models and life tables. J R Stat Soc (B) 34: 187-202, 1972
28. Glaser JS: Gliomas of the anterior visual pathways in children: Rationale for conservative management. In: Brokhurst RJ, Borouchoff SA, Hutchinson BT (eds) Controversy in Ophthalmology. W.B. Saunders Company, Philadelphia, 1977, pp 897-906
29. Packer RJ, Savino PJ, Bilaniuk LT, Zimmermann RA, Schatz NJ, Rosenstock JG, Nelson DS, Jarrett PD, Bruce DA, Schut L: Chiasmatic gliomas of childhood: a reappraisal of natural history and effectiveness of cranial irradiation. Child's Brain 10: 393-403, 1983
30. Deliganis AV, Geyer RJ, Berger MS: Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma. Neurosurgery 38: 1114-1119, 1996
31. Listernick R, Charrow J, Greenwald M, Esterly NB: Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study. J Pediatr 125: 63-66, 1994
32. Russel DS, Rubinstein LJ: Gliomas of the optic nerve and chiasms. In: Pathology of Tumours of the Nervous System, edn 5, Williams & Wilkins, Baltimore, 1989, pp 370-376
33. Blatt J, Jaffe R, Deutsch M, Adkins JC: Neurofibromatosis and childhood tumors. Cancer 57: 1225-1229, 1986
34. Riccardi VM: Von Recklinhausen neurofibromatosis. N Engl J Med 305: 1617-1627, 1981
35. Dirks PB, Jay V, BeckerLE, Drake JM, Humphreys RP, Hoffman HJ, Rutka JT: Development of anaplastic changes in low-grade astrocytoma of childhood. Neurosurgery 34: 68-78, 1994
36. Brzowski AE, Bazan C, Mumma JV, Ryan SG: Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology 42: 679-681, 1992
37. Liu GT, Lessel S: Spontaneous visual improvement in chiasmal gliomas. Am J Ophthalmol 114: 193-201, 1992